Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
|---|---|---|
| Operating cash flow (direct method) | ||
| Cash income from operating activities | -1 | |
| Other cash income from operating activities | ---- | ---1 |
| Cash paid | -4.82%-993.2K | -947.55K |
| Payments to suppliers for goods and services | -4.82%-993.2K | ---947.55K |
| Direct interest received | 61.44%107.02K | --66.29K |
| Operating cash flow | -0.56%-886.19K | ---881.27K |
| Investing cash flow | ||
| Cash flow from continuing investing activities | -281.38%-2.62M | -687.81K |
| Capital expenditure reported | -225.04%-2.93M | ---902.81K |
| Net other investing changes | 44.82%311.36K | --215K |
| Cash from discontinued investing activities | ||
| Investing cash flow | -281.38%-2.62M | ---687.81K |
| Financing cash flow | ||
| Cash flow from continuing financing activities | 1.56%3.28M | 3.23M |
| Net common stock issuance | 1.56%3.28M | --3.23M |
| Cash from discontinued financing activities | ||
| Financing cash flow | 1.56%3.28M | --3.23M |
| Net cash flow | ||
| Beginning cash position | 207.30%2.46M | --800.75K |
| Current changes in cash | -113.85%-229.85K | --1.66M |
| End cash Position | -9.34%2.23M | --2.46M |
| Free cash from | -114.16%-3.82M | ---1.78M |
| Accounting Standards | US-GAAP | US-GAAP |